NCT01239316 2016-01-14Vismodegib in Treating Younger Patients With Recurrent or Refractory MedulloblastomaNational Cancer Institute (NCI)Phase 2 Completed12 enrolled 11 charts
NCT00822458 2014-04-02GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous TreatmentNational Cancer Institute (NCI)Phase 1 Completed34 enrolled